Duality Advisers, LP Amgen Inc Transaction History

Duality Advisers, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 27, 2023	BUY	$225.79 - $275.2 $858,453 - $1.05 Million	3,802 New	3,802 $919,000
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $415,970 - $462,902	-1,803 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $437,662 - $484,169	-1,996 Reduced 52.54%	1,803 $436,000
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $755,545 - $864,652	3,799 New	3,799 $855,000
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $489,070 - $573,004	-2,304 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $538,168 - $597,058	2,304 New	2,304 $562,000
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $4.44 Million - $5.18 Million	-20,013 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $4.33 Million - $5.16 Million	20,013 New	20,013 $4.6 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $371,450 - $413,083	-1,583 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$197.81 - $242.74 $313,133 - $384,257	1,583 New	1,583 $373,000
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $11.5 Million - $14.8 Million	-60,690 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $10.6 Million - $12.7 Million	60,690 New	60,690 $11.7 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $4.98 Million - $5.83 Million	-29,850 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $1.7 Million - $1.91 Million	9,390 Added 45.89%	29,850 $5.67 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $3.65 Million - $4.26 Million	20,460 New	20,460 $3.98 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.